Your browser doesn't support javascript.
loading
Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of ß-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management.
Traeger-Synodinos, Joanne; Vrettou, Christina; Sofocleous, Christalena; Zurlo, Matteo; Finotti, Alessia; Gambari, Roberto.
Afiliação
  • Traeger-Synodinos J; Laboratory of Medical Genetics, National and Kapodistrian University of Athens, St. Sophia's Children's Hospital, 11527 Athens, Greece.
  • Vrettou C; Laboratory of Medical Genetics, National and Kapodistrian University of Athens, St. Sophia's Children's Hospital, 11527 Athens, Greece.
  • Sofocleous C; Laboratory of Medical Genetics, National and Kapodistrian University of Athens, St. Sophia's Children's Hospital, 11527 Athens, Greece.
  • Zurlo M; Department of Life Sciences and Biotechnology, 40124 Ferrara, Italy.
  • Finotti A; Department of Life Sciences and Biotechnology, 40124 Ferrara, Italy.
  • Gambari R; Center "Chiara Gemmo and Elio Zago" for the Research on Thalassemia, Department of Life Sciences and Biotechnology, University of Ferrara, 44121 Ferrara, Italy.
Int J Mol Sci ; 25(6)2024 Mar 17.
Article em En | MEDLINE | ID: mdl-38542374
ABSTRACT
In this short review, we presented and discussed studies on the expression of globin genes in ß-thalassemia, focusing on the impact of α-globin gene expression and α-globin modifiers on the phenotype and clinical severity of ß-thalassemia. We first discussed the impact of the excess of free α-globin on the phenotype of ß-thalassemia. We then reviewed studies focusing on the expression of α-globin-stabilizing protein (AHSP), as a potential strategy of counteracting the effects of the excess of free α-globin on erythroid cells. Alternative processes controlling α-globin excess were also considered, including the activation of autophagy by ß-thalassemia erythroid cells. Altogether, the studies reviewed herein are expected to have a potential impact on the management of patients with ß-thalassemia and other hemoglobinopathies for which reduction in α-globin excess is clinically beneficial.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talassemia beta / Hemoglobinopatias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talassemia beta / Hemoglobinopatias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article